Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA." The Lancet , 2023
Facial Offer Aquafirm XS Intro Facial, $169 Perfect for a brighter tone, refined texture, deep hydration, and a clear plan forward.Includes In depth skin consultation and goal setting Advanced digital skin imaging with baseline photos, surface and subsurface, Aquafirm XS facial Personalized plan to achieve your skin goals Why start with Aquafirm XS Aquafirm gently refines and re-hydrates the skin so your advanced treatments perform at their best
Ozempic was originally developed for the management of type 2 diabetes
Youll be amazed at how much better your body feels when its supported the right way
Current phase 3 evidence says orforglipron produced greater blood sugar reduction and greater weight loss than oral semaglutide in the ACHIEVE-3 trial
Safe needle disposal Every used needle, syringe, and pen needle goes into a sharps container
US$ 25.08
US$ 24.75
US$ 29.65
US$ 28.77
US$ 20.82
US$ 28.03
US$ 25.48
